The growing spread of COVID-19 has changed the ways we live and work, and a=
t this time, there are more questions than answers. As we continue to find =
normalcy in our daily routines, we realize that continuity is vital from a =
business perspective. The life science industry plays a critical role in th=
e delivery and innovation of medicine to combat and prevent disease, such a=
s the novel coronavirus.



Join leaders from the life sciences industry as they identify a path toward=
s finding the right balance during these challenging times and provide insi=
ght on the role of ethics and compliance officers in addressing critical to=
pics, such as:

• Our responsibility =
  to patients and patient care, including privacy considerations (HIPAA, GDPR=
  ), the human impact of supply chain disruptions, Antitrust, and price gougi=
  ng considerations.
  
  
  
• Physician access an=
  d business impact on sales and marketing. Specifically, how does a company =
  stay compliant with regulations and ensure adequate access to customers? Co=
  mpliance professionals need to align with Commercial to ensure safe access =
  to customers, identify alternatives to current sales targets, and address t=
  he impact on incentive compensation to minimize risk.
  
  
  
• The importance of m=
  aintaining a flexible control environment and due diligence. When dealing w=
  ith a crisis, are there specific controls that can be flexible? If so, adeq=
  uate documentation should be maintained to demonstrate modifications made d=
  uring the crisis and plans to return to baseline.
  
  
  
• Additional consider=
  ations include GXP's during vaccine development, risk mitigation during fas=
  t-tracking vaccine production, and the impact on clinical trials.